Sayson, Khimberlie .
HRN: 26-18-59 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2024
CEFUROXIME 1.5GM (VIAL)
11/10/2024
11/11/2024
IV
1.5g
Q8
S/p CS
Waiting Final Action
11/10/2024
CEFUROXIME 500MG (TAB)
11/11/2024
11/18/2024
PO
500mg
BID
S/p CS
Waiting Final Action
11/10/2024
CEFUROXIME 500MG (TAB)
11/10/2024
11/16/2024
PO
500 Mg Tab
BID
SP LTCS
Waiting Final Action
11/10/2024
METRONIDAZOLE 500MG (TAB)
11/10/2024
11/16/2024
PO
500 Mg Tab
TID
SP LTCS
Waiting Final Action